EBITDA Growth
16.43%
TTM · Period ending:
SYRE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported16.43%period ending
Latest reported16.43%period ending
SYRE TTM EBITDA YoY % (-26.35% → 16.43%)
Year-over-year change
High-resolution chart · PNG
SYRE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 16.4277% | |
| 3.6572% | |
| 18.0466% | |
| 17.6632% | |
| -35.6642% | |
| -36.4067% | |
| -63.4293% | |
| -103.71% | |
| -98.15% | |
| -101.2998% | |
| -54.7852% | |
| -16.7874% | |
| 3.6838% | |
| -8.3056% | |
| -28.3059% | |
| -26.1095% | |
| -33.0061% | |
| 11.5979% | |
| 20.3889% | |
| 16.7887% | |
| 23.2921% | |
| 2.1618% | |
| -0.712% | |
| -8.9098% | |
| -32.4206% | |
| -48.8983% | |
| -76.9227% | |
| -100.9645% | |
| -96.7575% | |
| -86.0446% | |
| -64.6977% | |
| -38.3877% | |
| -30.5451% | |
| -24.6949% | |
| -25.9576% | |
| -30.3336% | |
| -42.3445% | |
| -76.6451% | |
| -93.9604% | |
| -94.0635% | |
| -70.6981% | |
| -27.0108% | |
| -26.3478% |